# Rani Therapeutics Holdings, Inc.: filings

RANI · Nasdaq · CIK 1856725 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rani.md) · [Financials](/companies/rani/financials.md) · [Filings](/companies/rani/filings.md) · [Insiders](/companies/rani/insiders.md)

## Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 162, 8-K 63, 3 20, 10-Q 16, 3/A 11, CORRESP 10, 424B5 9, SCHEDULE 13G 8, S-8 7, DEFA14A 6, EFFECT 6, SCHEDULE 13G/A 6, UPLOAD 6, 10-K 5, DEF 14A 5, S-3 5, SC 13D/A 5, ARS 3, SC 13D 3, SCHEDULE 13D/A 3, DEF 14C 2, PRE 14C 2, S-1/A 2, SC 13G 2, 424B4 1, 424B7 1, 4/A 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, NT 10-Q 1, S-1 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:16 ET | [10-Q](/filings/0001193125-26-349245.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349245 |
| 2026-08-13 | 16:11 ET | [8-K](/filings/0001193125-26-349197.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349197 |
| 2026-08-04 | 08:05 ET | [8-K](/filings/0001193125-26-331594.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-331594 |
| 2026-06-30 | 18:54 ET | [8-K](/filings/0001856725-26-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001856725-26-000003 |
| 2026-05-29 | 18:12 ET | [8-K](/filings/0001193125-26-245636.md) | 5.07 Shareholder vote results | 0001193125-26-245636 |
| 2026-05-28 | 17:47 ET | [SCHEDULE 13D/A](/filings/0001699737-26-000014.md) | Ownership report, active investor, amended | 0001699737-26-000014 |
| 2026-05-27 | 20:41 ET | [8-K](/filings/0001193125-26-239977.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-239977 |
| 2026-05-15 | 16:10 ET | [10-Q](/filings/0001193125-26-226703.md) | Quarterly report, period 2026-03-31 | 0001193125-26-226703 |
| 2026-05-15 | 16:08 ET | [8-K](/filings/0001193125-26-226691.md) | 2.02 Results of operations; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-226691 |
| 2026-04-16 | 16:46 ET | [DEF 14A](/filings/0001140361-26-015157.md) | Proxy statement, period 2026-05-28 | 0001140361-26-015157 |
| 2026-03-26 | 16:43 ET | [10-K](/filings/0001193125-26-126417.md) | Annual report, period 2025-12-31 | 0001193125-26-126417 |
| 2026-03-26 | 16:10 ET | [8-K](/filings/0001193125-26-126240.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126240 |
| 2026-01-02 | 17:27 ET | [8-K](/filings/0001193125-26-001098.md) | 1.02 Termination of a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-001098 |
| 2025-11-06 | 16:35 ET | [10-Q](/filings/0001193125-25-269774.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269774 |
| 2025-11-06 | 16:30 ET | [8-K](/filings/0001193125-25-269722.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269722 |
| 2025-10-30 | 19:50 ET | [SCHEDULE 13D](/filings/0001699737-25-000014.md) | Ownership report, active investor | 0001699737-25-000014 |
| 2025-10-27 | 21:49 ET | [SCHEDULE 13D/A](/filings/0001873082-25-000003.md) | Ownership report, active investor, amended | 0001873082-25-000003 |
| 2025-10-27 | 06:03 ET | [8-K](/filings/0001193125-25-250614.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-250614 |
| 2025-10-22 | 19:11 ET | [SCHEDULE 13D/A](/filings/0001104659-25-101616.md) | Ownership report, active investor, amended | 0001104659-25-101616 |
| 2025-10-17 | 07:38 ET | [8-K](/filings/0001193125-25-241963.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-241963 |
| 2025-08-07 | 16:15 ET | [10-Q](/filings/0000950170-25-105045.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105045 |
| 2025-08-07 | 16:07 ET | [8-K](/filings/0000950170-25-104998.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104998 |
| 2025-07-16 | 14:14 ET | [8-K](/filings/0001193125-25-159793.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159793 |
| 2025-06-26 | 16:06 ET | [8-K](/filings/0000950170-25-090384.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-090384 |
| 2025-05-29 | 16:09 ET | [8-K](/filings/0000950170-25-078949.md) | 5.07 Shareholder vote results | 0000950170-25-078949 |
| 2025-05-20 | 08:59 ET | [8-K](/filings/0001193125-25-122872.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-122872 |
| 2025-05-13 | 16:15 ET | [10-Q](/filings/0000950170-25-070382.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070382 |
| 2025-05-13 | 16:10 ET | [8-K](/filings/0000950170-25-070344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070344 |
| 2025-05-06 | 17:15 ET | [8-K](/filings/0000950170-25-064624.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-064624 |
| 2025-04-30 | 08:00 ET | [8-K](/filings/0000950170-25-060586.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-060586 |
| 2025-04-16 | 08:02 ET | [DEF 14A](/filings/0001140361-25-014078.md) | Proxy statement, period 2025-05-28 | 0001140361-25-014078 |
| 2025-04-09 | 16:21 ET | [8-K](/filings/0000950170-25-052527.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-052527 |
| 2025-03-31 | 16:15 ET | [10-K](/filings/0000950170-25-047740.md) | Annual report, period 2024-12-31 | 0000950170-25-047740 |
| 2025-03-31 | 16:07 ET | [8-K](/filings/0000950170-25-047701.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047701 |
| 2024-11-14 | 08:20 ET | [10-Q](/filings/0000950170-24-126763.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126763 |
| 2024-11-14 | 08:10 ET | [8-K](/filings/0000950170-24-126753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126753 |
| 2024-10-17 | 16:32 ET | [SC 13D/A](/filings/0001104659-24-109546.md) | Ownership report, active investor, amended | 0001104659-24-109546 |
| 2024-10-16 | 06:06 ET | [8-K](/filings/0001193125-24-237838.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237838 |
| 2024-09-11 | 16:10 ET | [8-K](/filings/0000950170-24-105509.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-105509 |
| 2024-08-06 | 16:09 ET | [10-Q](/filings/0000950170-24-091793.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091793 |
| 2024-08-06 | 16:04 ET | [8-K](/filings/0000950170-24-091744.md) | 9.01 Financial statements and exhibits | 0000950170-24-091744 |
| 2024-07-23 | 06:06 ET | [8-K](/filings/0001193125-24-182549.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-182549 |
| 2024-07-12 | 17:19 ET | [8-K](/filings/0000950170-24-083284.md) | 7.01 Regulation FD disclosure | 0000950170-24-083284 |
| 2024-06-24 | 07:16 ET | [8-K](/filings/0001193125-24-166293.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-166293 |
| 2024-05-30 | 16:03 ET | [8-K](/filings/0000950170-24-066552.md) | 5.07 Shareholder vote results | 0000950170-24-066552 |
| 2024-05-06 | 16:09 ET | [10-Q](/filings/0000950170-24-053548.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053548 |
| 2024-05-06 | 16:04 ET | [8-K](/filings/0000950170-24-053527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053527 |
| 2024-04-17 | 08:00 ET | [DEF 14A](/filings/0001140361-24-020199.md) | Proxy statement, period 2024-05-29 | 0001140361-24-020199 |
| 2024-03-20 | 16:09 ET | [10-K](/filings/0000950170-24-034163.md) | Annual report, period 2023-12-31 | 0000950170-24-034163 |
| 2024-03-20 | 16:05 ET | [8-K](/filings/0000950170-24-034153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034153 |

Page 1 of 3. [Older](/companies/rani/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.